Abiopharma

Annual Reports and Related Documents:

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

Amended report for a meeting convened for May 7, 2026 – update of warrant allocation terms following discussions with institutional entities and the entities advising them

Change - Announcement of Appointment: Appointment of Chief Marketing Officer

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

Employee Stock Option/ Share Scheme: Notice of Use of Treasury Shares

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Change in Interest of Substantial Unitholders: CLG and CLA

Annual Reports and Related Documents:

Change - Announcement of Appointment: Appointment of Chief Commercial Officer

General Announcement: Minutes of Extraordinary General Meeting held on 9 April 2026